Federation des caisses Desjardins du Quebec’s Beam Therapeutics BEAM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.53K	Hold	232	–	–	﹤0.01%	2479
2025 Q4	$6.43K	Buy	232 +32	+16%	+$816	﹤0.01%	2381
2025 Q3	$4.85K	Hold	200	–	–	﹤0.01%	2465
2025 Q2	$3.4K	Sell	200 -800	-80%	-$13.9K	﹤0.01%	2329
2025 Q1	$19.5K	Buy	+1,000	New	+$26.2K	﹤0.01%	1745
2023 Q2	–	Sell	-20	Closed	-$612	–	2336
2023 Q1	$612	Hold	20	–	–	﹤0.01%	2197
2022 Q4	$782	Hold	20	–	–	﹤0.01%	2312
2022 Q3	$953	Hold	20	–	–	﹤0.01%	2352
2022 Q2	$774	Hold	20	–	–	﹤0.01%	2409
2022 Q1	$1.15K	Hold	20	–	–	﹤0.01%	2418
2021 Q4	$1.59K	Hold	20	–	–	﹤0.01%	2379
2021 Q3	$1.74K	Hold	20	–	–	﹤0.01%	2417
2021 Q2	$2.57K	Buy	+20	New	+$1.59K	﹤0.01%	2375

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BEAM Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 232 shares worth $5.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

Federation des caisses Desjardins du Quebec first reported a position in BEAM in Q2 2021 and has held it in 13 quarters since. The position peaked at $19.5K in Q1 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Federation des caisses Desjardins du Quebec held 232 shares of Beam Therapeutics worth $5.53K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Beam Therapeutics share count unchanged in Q1 2026.
Beam Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2479 holding.
Federation des caisses Desjardins du Quebec first reported a position in Beam Therapeutics in Q2 2021 and has held it in 13 quarters since.
Federation des caisses Desjardins du Quebec's Beam Therapeutics position peaked at $19.5K in Q1 2025.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.